Skip to Content
MilliporeSigma
All Photos(3)

Key Documents

SAB4200499

Sigma-Aldrich

Monoclonal Anti-NF1 antibody produced in mouse

clone NF1-333, tissue culture supernatant

Synonym(s):

Anti-DKFZp686J1293, Anti-NFNS, Anti-VRNF, Anti-WSS, Anti-neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease)

Sign Into View Organizational & Contract Pricing


About This Item

MDL number:
UNSPSC Code:
12352203
NACRES:
NA.41

biological source

mouse

conjugate

unconjugated

antibody form

tissue culture supernatant

antibody product type

primary antibodies

clone

NF1-333, monoclonal

form

buffered aqueous solution

mol wt

antigen ~250 kDa

species reactivity

rat, human, mouse

technique(s)

flow cytometry: 1:25-1:50/test using A549 cells.
western blot: 1:1000-1:2000 using Caco-2 total cell extracts.

isotype

IgM

UniProt accession no.

shipped in

dry ice

storage temp.

−20°C

target post-translational modification

unmodified

Gene Information

human ... NF1(4763)
mouse ... Nf1(18015)
rat ... Nf1(24592)

Looking for similar products? Visit Product Comparison Guide

General description

Monoclonal Anti-NF1 (mouse IgM isotype) is derived from the hybridoma NF1-333 produced by the fusion of mouse myeloma cells and splenocytes from BALB/c mice immunized with a synthetic peptide. Neurofibromin 1 (NF1) gene is located at chromosome 17q11.2. It is predominantly expressed in neurons, Schwann cells, oligodendrocytes, astrocytes and leukocytes. NF1 has two potentially functional domains; Ras GTPase activating protein (RasGAP)and phosphatidylinositol-transfer protein.

Immunogen

synthetic peptide corresponding to a sequence at the N-terminus of human NF1, conjugated to KLH. The isotype is determined by ELISA using Mouse Monoclonal Antibody Isotyping Reagents (Sigma ISO-2).

Application

Monoclonal Anti-NF1 antibody produced in mouse has been used in western blotting. It may be suitable for use in flow cytometry.

Biochem/physiol Actions

NF1 acts as a negative regulator of the p21-Ras/mitogen-activated protein kinase (MAPK) pathway as well as a tumor suppressor gene. Mutations in the neurofibromin 1 (NF1) gene is implicated in Neurofibromatosis type 1 (NF1) gene also known as von Recklinghausen peripheral or classical neurofibromatosis, is one of the most common autosomal dominant diseases. Consistent with a central role for neurofibromin in cellular function, recent cancer genome sequencing studies have found that somatic NF1 gene mutations occur not only in association with NF1, but also in a number of other common cancers. A variety of benign and malignant tumours are associated with NF1 and all involve tumorigenesis of neural crest-derived cells.

Physical form

Culture supernatant solution containing 15 mM sodium azide.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class

10 - Combustible liquids

wgk_germany

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

NF1 gene and neurofibromatosis 1
Rasmussen SA and Friedman JM
American Journal of Epidemiology, 151, 33-40 (2000)
neurofibromin 1 impairs natural Killer T-cell-Dependent antitumor immunity against a T-cell lymphoma
Liu J, et al.
Frontiers in immunology, 8, 1901-1901 (2018)
Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis
Laycock-van S, et al.
Human Genomics, 5(6), 623-623 (2011)
Neurofibromin: a general outlook
Trovo-Marqui AB and Tajara EH
Clinical Genetics, 70, 1-13 (2006)
Clinical and molecular characteristics of NF1-mutant lung cancer
Redig AJ, et al.
Clinical Cancer Research, 22(13), 3148-3156 (2016)

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service